Lincoln Pharmaceuticals' board is planning to consider and approve draft scheme of amalgamation of its subsidiary -- Lincoln Parenteral (The Transferor Company) with Lincoln Pharmaceuticals (The Transferee Company). The company’s board at their meeting to be held on September 19, 2019, to consider the same.
Lincoln Pharmaceuticals is engaged in the manufacture and marketing of affordable therapeutic products. The product range of the company includes Tablets, Capsules, Injectable, Syrups and Ointments.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1684.75 |
| Dr. Reddys Lab | 1225.20 |
| Cipla | 1229.95 |
| Zydus Lifesciences | 936.15 |
| Lupin | 2313.95 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: